This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Puma Biotechnology Inc (PBYI)

NYSE: Health Care

Company Profile
Price and Volume
Recent Price 238.57
52 Week High 279.37
52 Week Low 33.70
Avg. Daily Vol. (Mil) 0.57
Beta (3 year) -2.35
Share Related Items
Mkt Cap (Mil) 7,185.21
Shares Out (Mil) 30.12
Float (Mil) 20.23
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.40
Current Ratio 6.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 43.02
Price/Cash Flow -81.30
Per Share Data
Earnings -3.01
Sales 0.00
Book Value 5.55
Cash Flow -2.93
Business Summary
Puma Biotechnology Inc is a development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer.
General Information
10880 Wilshire Boulevard
Suite 2150
Los Angeles, CA 90024
www.pumabiotechnology.com
Industry : Drugs
Sector: Health Care
Employees: 72
CEO: Alan H. Auerbach
Short Interest
Current Month (Mil) 1.95
Previous Month (Mil) 2.00
Short Interest Ratio (Days) 6.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -45.30
Return on Investments -53.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
PBYI News

PBYI Puma Biotechnology Inc

Analysts Ratings for PBYI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 3
Moderate Buy 0 0 0 0
Hold 1 1 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PBYI ANALYST REPORT

Brokerage Partners

PBYI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs